Small Molecule Injectable Drugs Market Report Highlights The Competitive Scenario With Impact Of Drivers And Challenges 2028
Despite growth of biologic drugs, medicines based on small molecules remain important in the treatment of all types of diseases such as oncology disorders, infectious diseases, blood diseases, and cardiovascular diseases. Market Dynamics Market players are initiating production of injectable drugs in the new manufacturing facility, which is expected to drive growth of the global small molecule injectable drugs , over the forecast period. For instance, in August 2018, Pfizer Inc., a pharmaceutical and Biotechnology Corporation, announced injectable production at Portage in Kalamazoo, Michigan. The plant will enable Pfizer to produce injectable medicines for patients suffering from chronic diseases such as oncology, across the globe, as well as supporting the company’s supply capacity and production.